VIM and breast cancer: Other reports have suggested that the elevation of K18 expression in breast cancer patients correlates with favourable prognosis [38] and that the loss of K8 in conjunction with aberrant expression of vimentin correlates with early metastasis and poor prognosis [39], [40].